- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03215368
The Ma'Anshan Birth Cohort (MABC)
A Population-Based Prospective Cohort Study to Examine the Effects of Maternal Pregnancy Exposure on Adverse Pregnancy Outcomes, Child Health and Their Development.
The Ma'anshan Birth Cohort (MABC) is a population-based prospective pregnancy and birth cohort study that aims to explore the early environmental and genetic determinants of maternal and child health, with a focus on health outcomes including maternal health, children's cognitive and behavioral development, growth and physical development, video-screen behaviors, and asthma and allergic diseases.
MABC was officially launched in May 2013 at the Ma'anshan Maternal and Child Health Hospital in Anhui Province, and a total of 3,474 families were recruited as of September 2014 to continuously track the health status of mother-child pairs during pregnancy, delivery, and childhood, including basic family demographics, maternal pregnancy and birth history and past history, history of exposure to hazardous factors during pregnancy, children's diets and lifestyles, and children's physical and cognitive-behavioral development, MABC quantifies the attributional relationship between environmental chemicals, diet and nutrition, drug safety, psychological stress, lifestyle, biorhythm, endocrine metabolism and adverse birth outcomes, birth defects, neurodevelopmental disorders, developmental disabilities, etc., and identifies environmental, behavioral and genetic causative factors for birth defects and common developmental disorders, and identifies early warning signs and symptoms for early detection of birth defects. genetic causative factors, identify clinical biomarkers with early predictive effects, integrate and form a precise risk evaluation and early warning model, carry out regional comprehensive prevention and treatment applications, and promote the improvement of the quality of the birth population. Currently, MABC is conducting its 20th school-age follow-up visit.
Study Overview
Status
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Anhui
-
Ma'anshan, Anhui, China, 243011
- Ma'anshan Maternal and Child Health Care Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria
- Permanent residents of Ma'anshan city;
- Obstetric examination and delivery at Ma'anshan Maternal and Child Health Hospital;
- Mother's age ≥ 18 years old and gestational week ≤ 14 weeks;
- No serious neuropsychiatric disorders, with sufficient understanding and expression to complete the survey.
Exclusion criteria:
- Intellectual disability or other serious mental disorders;
- Suffering from serious underlying diseases and may have a significant impact on pregnancy outcome;
- Those with poor compliance and difficulty in follow-up.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Numbers of participants with pregnancy complications
Time Frame: At delivery
|
Including gestational diabetes, gestational hypertension, anemia, and hypothyroidism during pregnancy. Diagnosis by medical personnel at clinics |
At delivery
|
|
Numbers of participants with adverse pregnancy outcomes
Time Frame: At delivery
|
Including preterm birth, low birth weight, macrosomia, abortion, stillbirth, and birth defects. Hospital information system collection |
At delivery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight in kilogram changes during childhood
Time Frame: At birth and age at 42 days, 3 months, 6 months, 9 months, 1 year, 1.5 years, 2 years, 2.5 years, 3 years, 3.5 years, 4 years, 4.5years, 5 years, 6 years, 7 years, 8 years, 9 years, 10 years, 11years and 12 years
|
Measured by health professionals in the clinic.
|
At birth and age at 42 days, 3 months, 6 months, 9 months, 1 year, 1.5 years, 2 years, 2.5 years, 3 years, 3.5 years, 4 years, 4.5years, 5 years, 6 years, 7 years, 8 years, 9 years, 10 years, 11years and 12 years
|
|
Height in centimeter changes during childhood
Time Frame: At birth and age at 42 days, 3 months, 6 months, 9 months, 1 year, 1.5 years, 2 years, 2.5 years, 3 years, 3.5 years, 4 years, 4.5years, 5 years, 6 years, 7 years, 8 years, 9 years, 10 years, 11years and 12 years
|
Measured by health professionals in the clinic.
|
At birth and age at 42 days, 3 months, 6 months, 9 months, 1 year, 1.5 years, 2 years, 2.5 years, 3 years, 3.5 years, 4 years, 4.5years, 5 years, 6 years, 7 years, 8 years, 9 years, 10 years, 11years and 12 years
|
|
Early Child development
Time Frame: Age at 6 months, 48 months and 54 months
|
Measured by Ages&Stages Questionnaires (ASQ).
There are 6 questions in each of 5 domains of development: communication, gross motor, fine motor, problem-solving skills, and adaptive skills.
Each question is given a 10 (yes), 5 (sometimes), or 0 (not yet) score according to the parents' answers.
The sum scores (range from 0 to 300) and scores for each domain (range from 0 to 60) are calculated.
Chinese norms are available for each domain, and any domain screened <2 SDs below the mean is considered a positive screening.
A higher ASQ score means better development.
|
Age at 6 months, 48 months and 54 months
|
|
Child Psychological and Behavioural Development
Time Frame: Age at 48 months, 60 months and 72 months
|
Measured by Strengths and Difficulties Questionnaire(SDQ).
SDQ consisted of 25 entries scored on a 3-point scale from 0 to 2. 0: "Doesn't meet"; 1: "Somewhat meets"; 2: "Completely meets"; and the results were summarized into 5 factors: emotional factor, conduct factor, hyperactivity factor, peer factor, and pro-social factor, each with a score range of 0 to 10.
The results were categorized into five factors: Emotional, Conduct, Hyperactivity, Peer, and Pro-social, each of which has a score range of 0-10 points.
The sum of the scores of the first four factors is the total difficulty score of the SDQ, and the higher the score, the more serious the objective difficulty is.
The higher the score, the better the pro-social ability.
|
Age at 48 months, 60 months and 72 months
|
|
Child Intelligence quotient
Time Frame: At age of 54 months
|
Assessed by using Wechsler Preschool and Primary Scale of Intelligence-Fourth Edition-Chinese (WPPSI-IV(CN)), which can generate a full scale intelligence quotient score and five primary index scores including verbal comprehension, visual spatial, fluid reasoning, working memory, and processing speed.
Intelligence quotient ranges from 40 to 160, in which less than 70 is defined as mental retardation
|
At age of 54 months
|
|
Child Sexual Development Indicators
Time Frame: At ages of 9-15 years for boys, and 8-14 years for girls
|
Secondary sexual characters, Sexual hormones.
Staging of puberty using Tanners classification: Testicular size of boys assessed by Prader's testerometer suggests possible precocious puberty if testicular development occurs before the age of 9 years in boys, and if breast development occurs before the age of 7.5 years or first menstruation occurs before the age of 10 years in girls.
In order to further determine the existence and classification of precocious puberty, ultrasound examination of the uterus and ovaries for girls and ultrasound examination of the testes for boys are required.
In addition to the above tests, bone age assessment, bone density test, adrenal gland ultrasound, thyroid function, sex hormone 6, alpha-fetoprotein measurement, growth hormone stimulation test and gonadotropin-releasing hormone stimulation test are also performed to further confirm the diagnosis.
|
At ages of 9-15 years for boys, and 8-14 years for girls
|
|
Incidence of child overweight and obesity
Time Frame: At birth and age at 42 days, 3 months, 6 months, 9 months, 1 year, 1.5 years, 2 years, 2.5 years, 3 years, 3.5 years, 4 years, 4.5years, 5 years, 6 years, 7 years, 8 years, 9 years, 10 years, 11years and 12 years
|
Measured by health professionals in clinic.
|
At birth and age at 42 days, 3 months, 6 months, 9 months, 1 year, 1.5 years, 2 years, 2.5 years, 3 years, 3.5 years, 4 years, 4.5years, 5 years, 6 years, 7 years, 8 years, 9 years, 10 years, 11years and 12 years
|
|
Fetal Head Circumference
Time Frame: At delivery.
|
Measured by health professionals in clinic with ultrasound.
|
At delivery.
|
|
Fetal Abdominal Circumference
Time Frame: At delivery.
|
Measured by health professionals in clinic with ultrasound.
|
At delivery.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Fangbiao Tao, Anhui Medical University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20131195
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Birth Defects
-
National Human Genome Research Institute (NHGRI)CompletedCongenital Abnormalities | Birth Defects | Congenital DefectsUnited States
-
Children's Hospital of Fudan UniversityMinhang Maternal and Children Health Hospital; Songjiang Maternal and Children...Completed
-
Oslo University HospitalUniversity of BergenCompletedHeart Septal Defects, Atrial | Heart Defects,CongenitalNorway
-
National Human Genome Research Institute (NHGRI)Completed
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Heart Septal Defects, Atrial | Heart Septal Defects, Ventricular | Endocardial Cushion Defects | Defect, Congenital Heart
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Heart Septal Defects, Atrial | Heart Septal Defects, Ventricular | Endocardial Cushion Defects | Defect, Congenital Heart
-
Assiut UniversityNot yet recruitingCardiac Congenital Defects
-
SeptRx, Inc.UnknownHeart Septal Defects | Heart Defects, Congenital | Foramen Ovale, PatentGermany, France
-
Carag AGCompleted
-
Oslo University HospitalBioPhausiaCompletedHeart Defects, Congenital | Transposition of Great Vessels | Heart Septal Defects, Ventricular | Endocardial Cushion Defects